Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
The University of Texas MD Anderson Cancer Center · Breast Cancer Care · +3 more institutions
Abstract
No abstract available for this paper.
Citation impact
- FWCI
- 28.69
- Percentile
- 100%
- References
- 106
Authors
5- RNRita NahtaCorresponding
The University of Texas MD Anderson Cancer Center, Breast Cancer Care
- DYDihua Yu
Cellular Research (United States), The University of Texas MD Anderson Cancer Center, Breast Cancer Care, Breast Cancer Research Foundation, Molecular Oncology (United States)
- MHMien‐Chie Hung
Molecular Oncology (United States), The University of Texas MD Anderson Cancer Center, Cellular Research (United States), Breast Cancer Care, Breast Cancer Research Foundation
- GNGabriel N. Hortobágyi
Cellular Research (United States), The University of Texas MD Anderson Cancer Center, Breast Cancer Research Foundation, Molecular Oncology (United States), Breast Cancer Care
- FJFrancisco J. Esteva
The University of Texas MD Anderson Cancer Center, Molecular Oncology (United States), Cellular Research (United States), Breast Cancer Care, Breast Cancer Research Foundation
Topics & keywords
- Trastuzumab
- Cancer research
- Breast cancer
- PTEN
- Epidermal growth factor receptor
- Growth factor receptor
- Medicine
- Insulin-like growth factor 1 receptor
- Good health and well-being